AMANDA BEMBIC: Open Payments
NPI 1447600895 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 51 payments from 8 companies in 2025. Trend: 2023 $1,283 · 2024 $1,717 · 2025 $1,518
Food & beverage: $1,458Education: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $471 |
| GlaxoSmithKline, LLC. | 13 | $309 |
| Janssen Biotech, Inc. | 7 | $268 |
| ABBVIE INC. | 7 | $195 |
| Amgen Inc. | 7 | $162 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| SOBI, INC | 2 | $40 |
| Genentech USA, Inc. | 1 | $24 |
Products named: SAPHNELO, BENLYSTA, TREMFYA, SKYRIZI, ENBREL, COSENTYX, Kineret, Actemra.
Industry payments across PA — which companies pay providers there.
